SEC Insider Transactions from Granowitz Craig B.

Last updated: 2026-03-14 11:54 UTC | Total transactions: 30

Granowitz Craig B has filed 30 insider transactions across 1 company since February 2023.

Most recent transaction: a option exercise of 74226 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2026.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 74226 $0.00 74,227.0000 365,780,799 50.00% 0.02%
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer F Common Stock 109098 $1.47 323,430.0000 365,780,799 25.22% 0.03%
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 202260 $0.00 432,528.0000 365,780,799 87.84% 0.06%
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 74226 $0.00 230,268.0000 365,780,799 47.57% 0.02%
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 35790 $0.00 156,042.0000 365,780,799 29.76% 0.01%
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 202260 $0.00 404,520.0000 365,780,799 33.33% 0.06%
Feb. 28, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 35790 $0.00 0.0000 365,780,799 100.00% 0.01%
Feb. 12, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Stock Option (Right to Buy) 519920 $0.00 519,920.0000 365,780,799 9999.99% 0.14%
Feb. 12, 2026 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Restricted Stock Units 346610 $0.00 346,610.0000 365,780,799 9999.99% 0.09%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 27917 $0.00 75,543.0000 363,020,303 58.62% 0.01%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 35790 $0.00 111,333.0000 363,020,303 47.38% 0.01%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 74227 $0.00 185,560.0000 363,020,303 66.67% 0.02%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer F Common Stock 65308 $0.67 120,252.0000 363,020,303 35.20% 0.02%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 27917 $0.00 0.0000 363,020,303 100.00% 0.01%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 35790 $0.00 35,790.0000 363,020,303 50.00% 0.01%
Feb. 28, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 74227 $0.00 148,453.0000 363,020,303 33.33% 0.02%
Feb. 13, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Restricted Stock Units 606780 $0.00 606,780.0000 363,020,303 9999.99% 0.17%
Feb. 13, 2025 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Stock Option (Right to Buy) 910170 $0.00 910,170.0000 363,020,303 9999.99% 0.25%
Feb. 28, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 35790 $0.00 71,580.0000 0 33.33% 0.00%
Feb. 28, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 27916 $0.00 27,917.0000 0 50.00% 0.00%
Feb. 28, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer F Common Stock 31265 $2.62 47,626.0000 0 39.63% 0.00%
Feb. 28, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 35790 $0.00 78,891.0000 0 83.04% 0.00%
Feb. 28, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 27916 $0.00 43,101.0000 0 183.84% 0.00%
Feb. 8, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Stock Option (Right to Buy) 222680 $0.00 222,680.0000 0 9999.99% 0.00%
Feb. 8, 2024 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Restricted Stock Units 222680 $0.00 222,680.0000 0 9999.99% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer F Common Stock 12732 $2.17 15,185.0000 0 45.61% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Common Stock 27917 $0.00 27,917.0000 0 9999.99% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer M Restricted Stock Units 27917 $0.00 55,833.0000 0 33.33% 0.00%
Feb. 9, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Restricted Stock Units 107370 $0.00 107,370.0000 0 9999.99% 0.00%
Feb. 9, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Granowitz Craig B SVP, Chief Medical Officer A Stock Option (Right to Buy) 322110 $0.00 322,110.0000 0 9999.99% 0.00%